INITIO updates and comments on new studies
Article: https://telixpharma.com/news-views/health-canada-approves-illuccix-for-prostate-cancer-imaging/ Health Canada Approves Illuccix® for Prostate Cancer Imaging Telix announces that Health Canada has approved Illuccix® [kit for the preparation of gallium (68Ga) gozetotide
In the study of CAR-T with lymphoma, researchers are discovering that PET scans with FDG (a modified sugar molecule) predict long term response to CAR-T therapy. For patients who are not responding, this gives doctors time to switch to other treatment regimens without having to wait.
…The second generation Discovery PET/CT scanner at INITIO includes the ability to calculate the metabolic volume of a tumor, and we routinely report these emerging biomarkers to our referring physicians….
This new PET tracer compound, SMBT-1, focuses on astrocytes, which are the most abundant cell type in the brain, even more abundant than neurons. The tracer is able to selectively detect activated astrocytes, which may be a marker of undesirable brain inflammation which precedes cognitive deterioration.